Skip to main content
Clinical Trials/IRCT20211022052838N1
IRCT20211022052838N1
Recruiting
Phase 3

Comparison of the sedation effect of Dexmedetomidine and midazolam using the Richmond agitation sedation scale (RASS) in patients admitted to clinical toxicology intensive care unit

Esfahan University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Sedation before Intubation.
Sponsor
Esfahan University of Medical Sciences
Enrollment
60
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with American society of anesthesiologist (ASA) class 3 and 4 who are admitted in ICU of poisoned patients
  • Age between 18 to 80
  • Patients whom are going to be intubated
  • Not taking sedative drugs before admitting to intensive care unit (ICU)

Exclusion Criteria

  • known allergy to any of the drugs used in this study
  • advanced liver disease
  • Serum creatinine level above 200 micromol/liter
  • Unstable angina or acute myocardial infarction patients

Outcomes

Primary Outcomes

Not specified

Similar Trials